Sheela Ramamoorthy

Dr. Sheela Ramamoorthy

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2008 in Journal of General Virology
Verified
Journal Article
Open access
PDF file
TOTanja Opriessnig
Tanja Opriessnig
SRSheela Ramamoorthy
Sheela Ramamoorthy
DMD. M. Madson
D. M. Madson
APA. R. Patterson
A. R. Patterson
NPN. Pal
N. Pal
PHP. G. Halbur
P. G. Halbur
Porcine circovirus type 2 (PCV2) is divided into two genetic clusters designated PCV2a and PCV2b. The objectives of this study were to determine whether isolates from different clusters vary in virulence and to determine whether infection with PCV2a isolates induces protective immunity against subsequent infection with a recent PCV2b isolate. One-hundred and thirteen conventional specific-pathogen-free (SPF) pigs were assigned randomly to treatment groups and rooms: pigs inoculated with PCV2a cluster isolates (ISU-40895 or ISU-4838), pigs inoculated with PCV2b cluster isolates (NC-16845 or Can-17639) and uninoculated pigs. Necropsies were performed at 16 or 51 days post-inoculation (p.i.). There were no significant differences in PCV2-associated lymphoid lesions between PCV2a and PCV2b clusters; however, within the same cluster, significant differences were found between isolates: ISU-4838- and Can-17639-inoculated pigs had significantly (P<0.05) less severe lesions compared with ISU-40895- and NC-16845-inoculated pigs. To evaluate cross-protection, six pigs within each group were challenged at 35 days p.i. with an isolate from the heterologous cluster and were necropsied 51 days p.i. The severity of PCV2-associated lesions was reduced in pigs with prior exposure to an isolate from the heterologous cluster in comparison with singly inoculated pigs. Results indicate that the virulence of PCV2a and PCV2b isolates is not different in the conventional SPF pig model; however, the virulence of isolates within the same cluster differs. Increased virulence as reported to be associated with PCV2b isolates in the field was not observed under the conditions of this study. Moreover, cross-protection between PCV2a and PCV2b exists.

2 September 2008 in Animal Health Research Reviews
Verified
Journal Article
Closed access
SRSheela Ramamoorthy
Sheela Ramamoorthy
XMXiang-Jin Meng
Xiang-Jin Meng
Porcine circovirus type 2 (PCV2) is the primary causative agent for porcine circovirus-associated disease (PCVAD). PCVAD has been the cause of considerable economic losses to the pork industry worldwide. The disease is primarily characterized by wasting, enlarged lymph nodes, jaundice and weight loss in affected weanling pigs. Several other complex syndromes involving reproductive failure, enteritis, pneumonia and necrotizing dermatitis have also been associated with PCV2 infection. Lymphoid depletion, which is the hallmark lesion of PCVAD, predisposes the host to immunosuppression. Disease progression is further complicated by co-infections with other bacterial and viral pathogens. Despite the availability of effective vaccines for the last 2 years, newly emerging strains of the virus have been reported to cause more severe outbreaks in parts of the USA and Canada. While knowledge of the biology and pathogenesis of PCV2 has progressed considerably over the last 12 years since the disease was recognized, many questions still remain to be answered.

1 July 2017 in Veterinary Microbiology
Verified
Journal Article
Closed access
ZAZahra Afghah
Zahra Afghah
BWBrett Webb
Brett Webb
XMXiang-Jin Meng
Xiang-Jin Meng
SRSheela Ramamoorthy
Sheela Ramamoorthy

1 September 2006 in Infection and Immunity
Verified
Journal Article
Closed access
PDF file
YHYongqun He
Yongqun He
SRSherry Reichow
Sherry Reichow
SRSheela Ramamoorthy
Sheela Ramamoorthy
XDXicheng Ding
Xicheng Ding
RLRaju Lathigra
Raju Lathigra
SBStephen M. Boyle
Stephen M. Boyle
Brucellaspp. are facultative intracellular bacteria that cause brucellosis in humans and other animals.Brucellaspp. are taken up by macrophages, and the outcome of the macrophage-Brucellainteraction is a basis for establishment of a chronicBrucellainfection. Microarrays were used to analyze the transcriptional response of the murine macrophage-like J774.A1 cell line to infection with virulentBrucella melitensisstrain 16M. It was found that most significant changes in macrophage gene transcription happened early following infection, and global macrophage gene expression profiles returned to normal between 24 and 48 h postinfection. These findings support the observation that macrophages kill the majority ofBrucellacells at the early infection stage, but the survivingBrucellacells are able to avoid macrophage brucellacidal activity inside replicative phagosomes at the later infection stage. At 4 h postinfection, macrophage genes involved in cell growth, metabolism, and responses to endogenous stimuli were down-regulated, while the inflammatory response (e.g., tumor necrosis factor alpha and Toll-like receptor 2), the complement system, the responses to external stimuli, and other immune responses were up-regulated. It is likely that the most active brucellacidal activity happened between 0 and 4 h postinfection. Mitochondrion-associated gene expression, which is involved in protein synthesis and transport, electron transfer, and small-molecule transfer, and many other mitochondrial functions were significantly down-regulated at 4 h postinfection. Although there were both pro- and antiapoptosis effects,B. melitensis16M appears to inhibit apoptosis of macrophages by blocking release of cytochromecand production of reactive oxygen species in the mitochondria, thus preventing activation of caspase cascades.

9 March 2009 in Veterinary Pathology
Verified
Journal Article
Open access
DMD. M. Madson
D. M. Madson
APA. R. Patterson
A. R. Patterson
SRSheela Ramamoorthy
Sheela Ramamoorthy
NPN. Pal
N. Pal
XMXiang-Jin Meng
Xiang-Jin Meng
TOTanja Opriessnig
Tanja Opriessnig
Porcine circovirus type 2 (PCV2) is associated with reproductive failure in female pigs. However, the association of PCV2-positive semen in the pathogenesis has not been elucidated. The objectives of this study were to determine whether semen spiked with PCV2 causes infection in PCV2-naïve, mature female pigs and whether delivery of PCV2 via artificial insemination causes reproductive failure or fetal infection. Nine sows were randomly allocated into 3 groups of 3 sows each and artificially inseminated with PCV2 DNA-negative semen (group 1), PCV2 DNA-negative semen spiked with PCV2a (group 2), or PCV2b (group 3). All sows in groups 2 and 3 developed PCV2 viremia 7 to 14 days after insemination. None of the group 2 sows became pregnant, whereas all group 3 sows (3/3) farrowed at the expected date. At parturition, presuckle serum samples were collected, and live-born piglets, stillborn fetuses, and mummified fetuses were necropsied. All live-born piglets ( n = 8) in group 3 were PCV2 viremic at birth. Stillborn fetuses ( n = 2) had gross lesions of congestive heart failure. Mummified fetuses ( n = 25) varied in crown-rump length from 7 to 27 cm, indicating fetal death between 42 and 105 days of gestation. PCV2 antigen was detected in the myocardium by immunohistochemistry of 7/8 (88%) live-born piglets, 2/2 (100%) of the stillborn fetuses, and 25/25 (100%) of the mummified fetuses. In addition, 4/25 mummified fetuses had PCV2 antigen associated with smooth muscle cells and fibroblasts. The results of this study indicate that intrauterine administration of PCV2 causes reproductive failure in naïve sows.

1 December 2011 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
CDChen Dong
Chen Dong
JMJihong Meng
Jihong Meng
XDXing Dai
Xing Dai
JLJiu-Hong Liang
Jiu-Hong Liang
AFAlicia R. Feagins
Alicia R. Feagins
CTChong-Gee Teo
Chong-Gee Teo
Hepatitis E is recognized as a zoonosis, and swine are known reservoirs, but how broadly enzootic its causative agent, hepatitis E virus (HEV), is remains controversial. To determine the prevalence of HEV infection in animals, a serological assay with capability to detect anti-HEV-antibody across a wide variety of animal species was devised. Recombinant antigens comprising truncated capsid proteins generated from HEV-subgenomic constructs that represent all four viral genotypes were used to capture anti-HEV in the test sample and as an analyte reporter. To facilitate development and validation of the assay, serum samples were assembled from blood donors ( n = 372), acute hepatitis E patients ( n = 94), five laboratory animals (rhesus monkey, pig, New Zealand rabbit, Wistar rat, and BALB/c mouse) immunized with HEV antigens, and four pigs experimentally infected with HEV. The assay was then applied to 4,936 sera collected from 35 genera of animals that were wild, feral, domesticated, or otherwise held captive in the United States. Test positivity was determined in 457 samples (9.3%). These originated from: bison (3/65, 4.6%), cattle (174/1,156, 15%), dogs (2/212, 0.9%), Norway rats (2/318, 0.6%), farmed swine (267/648, 41.2%), and feral swine (9/306, 2.9%). Only the porcine samples yielded the highest reactivities. HEV RNA was amplified from one farmed pig and two feral pigs and characterized by nucleotide sequencing to belong to genotype 3. HEV infected farmed swine primarily, and the role of other animals as reservoirs of its zoonotic spread appears to be limited.